## Clinical Context β-Thalassemia major is an autosomal recessive disorder caused by mutations in the β-globin gene (chromosome 11). Over 300 different mutations have been identified, ranging from point mutations (missense, nonsense, splice site) to deletions. Identifying the specific mutation is essential for: - **Genetic counselling** of parents and siblings - **Prenatal diagnosis** in future pregnancies - **Carrier screening** in the family - **Prognosis** (some mutations are more severe) ## Why PCR + Sequencing/Allele-Specific PCR is Correct **Key Point:** For **point mutations** in a known gene, **PCR amplification followed by direct DNA sequencing** is the gold-standard, first-line molecular technique. ### Workflow: 1. **PCR amplification**: Primers flanking the suspected mutation site amplify the β-globin gene region from genomic DNA (blood sample). 2. **Direct sequencing** (Sanger sequencing): PCR product is sequenced; the exact nucleotide change is identified (e.g., codon 6: GAG→GTG = E6V, the sickle cell mutation; or codon 39: CAG→TAG = nonsense mutation in β-thalassemia). 3. **Alternative: Allele-specific PCR (AS-PCR)**: If the mutation is known in the family, AS-PCR using mutation-specific primers can rapidly confirm the genotype (faster, cheaper, but requires prior knowledge of the mutation). **High-Yield:** PCR is **rapid** (hours), **sensitive** (detects single nucleotide changes), **specific**, and **cost-effective** — ideal for point mutation detection in a known gene. ## Comparison of Blotting & PCR Techniques | Technique | Target | Detects | Suitable for Point Mutations? | Why Wrong Here? | |-----------|--------|---------|-------------------------------|------------------| | **Southern Blot** | DNA | RFLPs, large deletions, rearrangements | Only if mutation creates/destroys a restriction site (indirect); low sensitivity | Slow (days), labour-intensive, not ideal for point mutations unless they affect a restriction site | | **PCR + Sequencing** | DNA | Exact nucleotide sequence | **Yes — gold standard** | ✓ **CORRECT ANSWER** | | **Northern Blot** | RNA | mRNA expression levels | No | Detects *mRNA abundance*, not DNA mutation; β-thalassemia mutations affect mRNA splicing/stability, but Northern blot does not identify the *specific mutation* | | **Western Blot** | Protein | Globin chain expression, abnormal haemoglobin variants | No | Detects *protein*, not DNA; cannot identify the underlying genetic mutation; useful for phenotyping (e.g., HbS in sickle cell) but not for genetic diagnosis | **Clinical Pearl:** β-Thalassemia mutations are **heterogeneous**. A single family may carry a unique mutation. PCR + sequencing identifies the exact mutation, enabling accurate carrier testing and prenatal diagnosis. Southern blot was historically used (detects RFLPs linked to β-thalassemia mutations) but is now obsolete for this purpose. ## Diagnostic Algorithm for β-Thalassemia Genetic Testing ```mermaid flowchart TD A[Clinical diagnosis: β-thalassemia major]:::outcome --> B[Blood sample for genetic testing]:::action B --> C[PCR amplification of β-globin gene]:::action C --> D[Direct DNA sequencing<br/>or Allele-specific PCR]:::action D --> E{Mutation identified?}:::decision E -->|Yes| F[Confirm diagnosis<br/>Genetic counselling]:::outcome E -->|No| G[Expand sequencing<br/>or consider large deletion]:::action F --> H[Carrier screening in family<br/>Prenatal diagnosis option]:::outcome ``` **Mnemonic:** **PCR for Speed & Precision, Blots for Protein/RNA Bulk** — when you need to identify a *specific nucleotide change*, PCR + sequencing is the answer.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.